{
"id":"mk19_b_gm_s6",
"subspecialtyId":"gm2",
"title":"Men's Health",
"jsonContent":{
"type":"section",
"id":"mk19_b_gm_s6",
"title":{
"__html":"Men's Health"
},
"titleNode":{
"type":"section-title",
"hlId":"f7b776",
"children":[
"Men's Health"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_gm_s6_1",
"title":{
"__html":"Male Sexual Dysfunction"
},
"titleNode":{
"type":"section-title",
"hlId":"6d5e73",
"children":[
"Male Sexual Dysfunction"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_gm_s6_1_1",
"title":{
"__html":"Erectile Dysfunction"
},
"titleNode":{
"type":"section-title",
"hlId":"ab1668",
"children":[
"Erectile Dysfunction"
]
},
"children":[
{
"type":"p",
"hlId":"942f79",
"children":[
"Erectile dysfunction (ED) refers to the inability to achieve or maintain an erection necessary for satisfactory sexual performance. The most common causes are vascular disease; neurologic disease, including stroke and postoperative nerve injury; medications; androgen deficiency; and psychological issues."
]
},
{
"type":"p",
"hlId":"57a5ec",
"children":[
"Assessment of ED begins with obtaining a comprehensive history, including medical, surgical, sexual, and psychosocial histories. Clinicians should clarify whether the problem is attaining or maintaining erections, whether it occurs with masturbation or with partners, and whether nocturnal and early morning erections are present. The International Index of Erectile Function (",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"https://reference.medscape.com/calculator/377/international-index-of-erectile-function-iief-5",
"target":"_blank"
},
"children":[
"https://reference.medscape.com/calculator/377/international-index-of-erectile-function-iief-5"
]
},
") is a tool to rapidly assess ED symptoms and subsequently monitor treatment effect. An accurate medication list should be elicited because many medications are associated with ED ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t37",
"wrapId":"1",
"children":[
"Table 37"
]
}
]
},
")"
]
},
". Medical conditions commonly associated with ED include coronary atherosclerosis, diabetes mellitus, hyperlipidemia, hypertension, androgen deficiency, obesity, spinal cord injury, and prostate cancer therapy."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_b_gm_t37"
]
},
{
"type":"p",
"hlId":"5e37e1",
"children":[
"Psychogenic ED, which is ED due to psychological or interpersonal factors, is common and may coexist with other etiologies. ED that occurs with preserved ability to achieve nocturnal and early morning erections should raise suspicion for psychogenic ED. Psychogenic ED is more common in younger patients and in those with a history of sexual abuse."
]
},
{
"type":"p",
"hlId":"3bd723",
"children":[
"Physical examination should include assessment of heart rate, blood pressure, and body mass index as well as examination of genitalia and secondary sex characteristics. The American Urological Association (AUA) 2018 erectile dysfunction guideline recommends obtaining a morning total testosterone level for all patients. ED is a significant risk factor for coronary arteriosclerosis, and its presence without clear etiology should prompt evaluation for cardiovascular risk factors; screening for diabetes mellitus, hypertension, and hyperlipidemia should be performed. If hypothyroidism is suspected, a serum thyroid-stimulating hormone level should be obtained."
]
},
{
"type":"p",
"hlId":"ccfadf",
"children":[
"Nonpharmacologic treatment options include lifestyle modifications, such as smoking cessation, exercise, and weight optimization. Psychological counseling should be considered in patients with a psychosocial etiology. Phosphodiesterase-5 (PDE-5) inhibitors are first-line pharmacotherapy for ED and function by increasing the vasodilatory effects of endogenous nitric oxide. The PDE-5 inhibitors avanafil, sildenafil, tadalafil, and vardenafil are FDA approved for on-demand use, and each have a similar efficacy; tadalafil, the longest-acting PDE-5 inhibitor, is FDA approved for daily use. All PDE-5 inhibitors require sexual stimulation to be effective and should be taken on an empty stomach. Common side effects include dyspepsia, headache, flushing, dizziness, and visual disturbances. PDE-5 inhibitors should not be used concurrently with nitrates owing to the potential for severe hypotension. The third Princeton Consensus Conference provides guidelines for the safety of ED treatment in patients with known cardiovascular disease or risk factors ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t38",
"wrapId":"2",
"children":[
"Table 38"
]
}
]
},
")"
]
},
". Testosterone therapy may be considered with documented androgen deficiency after discussion of risks and benefits."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_b_gm_t38"
]
},
{
"type":"p",
"hlId":"5c9198",
"children":[
"Pharmacologic options for patients who have contraindications to PDE-5 inhibitors include intraurethral and injected intracavernosal alprostadil. Alprostadil causes arterial smooth-muscle relaxation, leading to penile vasodilation. Intracavernosal alprostadil appears to be the more effective formulation, although its use is associated with chronic fibrotic changes (4.9% incidence) and injection site pain. Priapism is a side effect of both formulations (approximately 1.9% incidence), and proper patient education is required."
]
},
{
"type":"p",
"hlId":"bcb7b5",
"children":[
"When pharmacotherapy is not an option, patients can be offered a vacuum erection device, which has been shown to be both safe and effective. Implantation of a penile prosthesis is reserved for patients in whom other management options fail."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s6_1_2",
"title":{
"__html":"Premature Ejaculation"
},
"titleNode":{
"type":"section-title",
"hlId":"6411fd",
"children":[
"Premature Ejaculation"
]
},
"children":[
{
"type":"p",
"hlId":"2f0610",
"children":[
"Premature ejaculation, or male early ejaculation, is one of the most common sexual disorders in men. It is defined as ejaculation with minimal stimulation that occurs earlier than desired. It is often associated with psychological distress, low self-esteem, anxiety, and depression. Intravaginal ejaculatory latency time is the amount of time for ejaculation to occur after penile intravaginal insertion and is frequently used as an objective measure of premature ejaculation. A cutoff time of less than 1 minute is considered abnormal when associated with psychological distress. Although the specific etiology is unknown, dysfunction of 5-hydroxytryptamine receptors and penile hypersensitivity are thought to be involved."
]
},
{
"type":"p",
"hlId":"deeaed",
"children":[
"Therapy is aimed at extending the time between vaginal penetration and ejaculation. Treatment options include pharmacotherapy (first line) and behavioral techniques. The most effective long-term (>8 weeks) pharmacologic therapy is the combination of a selective serotonin reuptake inhibitor (SSRI) and a PDE-5 inhibitor. Other long-term therapies demonstrated to be more effective than placebo are, in decreasing order of efficacy, topical anesthetics, paroxetine monotherapy, PDE-5 inhibitor monotherapy, other SSRI monotherapy, and clomipramine (a tricyclic antidepressant). Onset of effect differs among therapies. An increase in intravaginal ejaculatory latency time can be seen shortly after initiation with topic anesthetics. Response to SSRIs is more delayed but can be seen as soon as several days after initiation, with most patients achieving benefit within several weeks. SSRI efficacy may decrease after 6 to 12 months of daily use owing to upregulation of 5-hydroxytryptamine receptors. Behavioral therapy should also be considered and may be used in combination with pharmacotherapy."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s6_1_3",
"title":{
"__html":"Decreased Libido"
},
"titleNode":{
"type":"section-title",
"hlId":"49642e",
"children":[
"Decreased Libido"
]
},
"children":[
{
"type":"p",
"hlId":"ee1e14",
"children":[
"Decreased libido is defined as a reduced desire or inclination to engage in sexual activities, sexual thoughts, or fantasies. When associated with concomitant marked personal or interpersonal distress, the condition is termed hypoactive sexual desire disorder. Although decreased libido is commonly experienced as part of normal aging, numerous medical and psychiatric conditions can cause decreased libido; these include alcohol use, mood disorders, and systemic illness. Medications associated with erectile dysfunction similarly can induce decreased libido. Treatment involves addressing the underlying causative factors. Testosterone treatment should be considered only when sexual dysfunction is accompanied by documented androgen deficiency and after a discussion of risks and benefits of treatment with the patient."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"3604b9",
"children":[
"Erectile dysfunction is a significant risk factor for coronary arteriosclerosis, and its presence without clear etiology should prompt evaluation for cardiovascular risk factors."
]
},
{
"type":"keypoint",
"hlId":"76c9ab",
"children":[
"Oral phosphodiesterase-5 inhibitors are first-line medical therapy for erectile dysfunction; however, they are contraindicated in patients taking nitrates."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s6_2",
"title":{
"__html":"Reproductive Counseling and Male Sterilization"
},
"titleNode":{
"type":"section-title",
"hlId":"808751",
"children":[
"Reproductive Counseling and Male Sterilization"
]
},
"children":[
{
"type":"p",
"hlId":"988e88",
"children":[
"Three forms of male contraception are available: male condoms, the withdrawal method (withdrawing penis from vagina before ejaculation), and vasectomy. The efficacy of these contraceptive options are described in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t39",
"wrapId":"3",
"children":[
"Table 39"
]
}
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_b_gm_t39"
]
},
{
"type":"p",
"hlId":"b47677",
"children":[
"Vasectomy, or male sterilization, is an office surgical procedure performed under local anesthesia in which the vas deferens is either occluded or severed to prevent transport of spermatozoa during ejaculation. Vasectomy, considered both highly safe and effective, appears to be underutilized compared with female sterilization (tubal ligation)."
]
},
{
"type":"p",
"hlId":"02754d",
"children":[
"Men interested in undergoing vasectomy should be counseled that the procedure is intended to be permanent and that it does not result in immediate sterility. Patients must use another contraceptive until azoospermia is confirmed by postvasectomy semen analysis. Complications are generally minor and include local bleeding and infection. Asymptomatic spermatic granuloma formation is common but symptomatic granulomas are infrequent (approximately 5%); granulomas typically resolve within 3 to 4 weeks with conservative treatment, such as NSAIDs. Vasectomy does not increase the risk for advanced or high-grade prostate cancer. Less than 1% of patients require repeat vasectomy. Patients who desire fertility after vasectomy can attempt either vasectomy reversal or sperm retrieval as part of the ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"in vitro"
]
},
" fertilization process."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s6_3",
"title":{
"__html":"Androgen Deficiency"
},
"titleNode":{
"type":"section-title",
"hlId":"ffbf6d",
"children":[
"Androgen Deficiency"
]
},
"children":[
{
"type":"p",
"hlId":"df97a6",
"children":[
"As men age, serum total testosterone levels gradually decline. The diagnosis of androgen deficiency should only be made when a patient has two separate early morning serum total testosterone levels less than 300 ng/dL (10.4 nmol/L) combined with suggestive symptoms and/or signs ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t40",
"wrapId":"4",
"children":[
"Table 40"
]
}
]
},
")"
]
},
". Both the Endocrine Society and the AUA recommend against screening for androgen deficiency in asymptomatic men. Assessment of free and bioavailable testosterone should be reserved for patients with serum total testosterone levels in the low-normal range and for patients in whom alterations in sex hormone–binding globulin (SHBG) levels are suspected. Increased SHBG levels are found in men of advanced age or with liver disease, whereas decreased SHBG levels can occur with obesity, diabetes/insulin resistance, and glucocorticoid use."
]
},
{
"type":"inline-wrap",
"wrapId":"4",
"contentIds":[
"mk19_b_gm_t40"
]
},
{
"type":"p",
"hlId":"0b71e5",
"children":[
"According to the ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.acpjournals.org/doi/10.7326/M19-0882?_ga=2.170277728.111212823.1635945117-749714997.1560786171#f2-M190882",
"target":"_blank"
},
"children":[
"American College of Physicians (ACP) recommendations"
]
},
" , the decision to initiate testosterone therapy should be individualized, involve shared decision making with the patient, and include a thorough discussion of benefits and risks. According to ACP, clinicians should consider testosterone therapy in patients with androgen deficiency to improve sexual dysfunction but avoid its use for improving vitality, energy levels, physical function, or cognition. Patients should be informed that evidence is insufficient to clearly describe the effect of testosterone therapy on the risk for development of prostate cancer, venous thromboembolism, and cardiovascular disease. The AUA recommends obtaining a baseline hemoglobin level and hematocrit and, in patients older than 40 years, a serum prostate-specific antigen (PSA) level. If a patient's hematocrit is greater than 50%, testosterone therapy should be withheld until the polycythemia is further evaluated. Persistently elevated serum PSA levels should be evaluated before initiation of testosterone therapy."
]
},
{
"type":"p",
"hlId":"841716",
"children":[
"If testosterone therapy is initiated, symptoms should be reevaluated within 12 months and periodically thereafter. Clinicians should adjust the patient's testosterone dose to achieve a serum total testosterone level in the middle tertile of the normal reference range (450-600 ng/dL [15.6-20.8 nmol/L]) while monitoring symptoms. In men with androgen deficiency and sexual dysfunction who experience no symptom improvement despite normalization of testosterone levels, testosterone treatment should be discontinued."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"a21fc0",
"children":[
"The diagnosis of androgen deficiency should only be made when a patient has two separate early morning serum total testosterone levels less than 300 ng/dL (10.4 nmol/L) combined with suggestive symptoms and/or signs."
]
},
{
"type":"keypoint",
"hlId":"f95a21",
"children":[
"Clinicians should consider testosterone therapy in patients with androgen deficiency to improve sexual dysfunction but should avoid its use for improving vitality, energy levels, physical function, or cognition."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s6_4",
"title":{
"__html":"Benign Prostatic Hyperplasia"
},
"titleNode":{
"type":"section-title",
"hlId":"9e6504",
"children":[
"Benign Prostatic Hyperplasia"
]
},
"children":[
{
"type":"p",
"hlId":"e2a465",
"children":[
"Benign prostatic hyperplasia (BPH) is a histologic diagnosis characterized by smooth muscle and epithelial cell proliferation in the prostate's transition (periurethral) zone, which can lead to urethral compression and subsequent impaired emptying of the bladder, bladder distention, and detrusor muscle dysfunction. The prevalence of BPH increases dramatically with age. BPH frequently causes lower urinary tract symptoms (LUTS) but can also be asymptomatic. LUTS can be divided into obstructive voiding or bladder storage (irritative) symptoms. Obstructive voiding symptoms include difficulty initiating urination, weak urinary stream, dribbling, straining to void, urinary hesitancy, and incomplete bladder emptying. Bladder storage symptoms include nocturia, dysuria, and urinary frequency and urgency."
]
},
{
"type":"p",
"hlId":"ce1092",
"children":[
"LUTS is not specific to BPH ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t41",
"wrapId":"5",
"children":[
"Table 41"
]
}
]
},
")"
]
},
". Patients should be asked about prior sexually transmitted infections, urethral trauma, and urologic procedures. A comprehensive assessment of both prescription and over-the-counter medications should be performed. Anticholinergics (antihistamines and tricyclic antidepressants) can lead to detrusor muscle dysfunction with decreased bladder contractility. Decongestants (sympathomimetics) bind to α-receptors, which can lead to bladder outlet obstruction. Opioid use can also result in urinary retention. Lifestyle factors can contribute to LUTS, and fluid intake and consumption of bladder irritants, including alcohol, caffeine, and acidic and spicy foods, should be determined. The AUA Symptom Index (AUA-SI), a validated seven-item questionnaire, can be used to objectively assess LUTS severity (",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"https://urology.weillcornell.org/sites/default/files/aua_symptom_score_web.pdf",
"target":"_blank"
},
"children":[
"https://urology.weillcornell.org/sites/default/files/aua_symptom_score_web.pdf"
]
},
") and determine appropriate treatment and response. The International Prostate Symptom Score (IPSS) includes the AUA-SI and an additional question on quality of life."
]
},
{
"type":"inline-wrap",
"wrapId":"5",
"contentIds":[
"mk19_b_gm_t41"
]
},
{
"type":"p",
"hlId":"97fe04",
"children":[
"All patients with LUTS should undergo digital rectal examination to assess prostate size and contour, rectal sphincter tone, and perineal sensation. Larger prostate size suggests increased risk for progression of LUTS. Prostate tenderness or bogginess suggests prostatitis. A prostate nodule raises concern for prostate cancer. Abnormal rectal tone and perineal sensation suggests an underlying neurologic disorder. The AUA recommends performing urinalysis in all patients with LUTS. In addition, a PSA level should be obtained in patients who meet criteria for PSA-based prostate cancer screening and who desire screening (see ",
{
"type":"cross-reference",
"target":"mk19_b_gm_s1_2_3_5_2",
"children":[
"Routine Care of the Healthy Patient"
]
},
")."
]
},
{
"type":"p",
"hlId":"47a07f",
"children":[
"The goal of treating LUTS secondary to BPH is symptom amelioration. Active surveillance is recommended for patients with mild symptoms (AUA-SI score <8) and those with more severe disease (AUA-SI >8) who are not bothered by their symptoms. Lifestyle modifications, including minimizing fluid intake around bedtime and avoiding bladder irritants, such as caffeine and alcohol, should be offered to all patients. Patients with bladder storage symptoms may benefit from scheduled voiding and pelvic floor muscle strengthening exercises. Symptoms should be reassessed annually using the AUA-SI or IPSS."
]
},
{
"type":"p",
"hlId":"1a258e",
"children":[
"In patients with bothersome moderate to severe symptoms (AUA-SI score >8), pharmacotherapy is recommended. Patients should be evaluated 4 to 12 weeks after initiating treatment to assess response to therapy. Therapeutic response can be monitored using the AUA-SI or IPSS; a decrease in AUA-SI score by 3 or more points represents clinically significant improvement."
]
},
{
"type":"p",
"hlId":"9d687b",
"children":[
"α-Blockers are considered first-line pharmacotherapy and function by promoting smooth muscle relaxation; they do not affect disease progression. Symptom improvement is generally seen within 48 hours of initiation, with maximal improvement noted within several weeks. Nonspecific α-blockers (alfuzosin, doxazosin, prazosin, and terazosin) block both α",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1A"
]
},
" prostate receptors and α",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1B"
]
},
" smooth muscle receptors in blood vessels and can be associated with orthostasis and lightheadedness. These agents should be started at low doses and slowly titrated upward. Silodosin and tamsulosin, which are α",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1A"
]
},
"-specific α-blockers, are less likely to cause orthostasis and do not require dose titration; however, they are more likely to cause retrograde ejaculation. If cataract surgery is planned, initiation of α-blocker therapy should be delayed owing to possible development of intraoperative floppy iris syndrome, a condition characterized by impaired pupil dilation and increased risk for perioperative complications. Caution should be exercised with concomitant PDE-5 inhibitor use owing to the possibility of hypotension, although PDE-5 inhibitors, especially daily use of tadalafil, may improve LUTS and be a reasonable option irrespective of comorbid erectile dysfunction. The combination of tadalafil with α-blockers offers no advantages in symptom improvement over either agent alone and should not be offered."
]
},
{
"type":"p",
"hlId":"c6968a",
"children":[
"5α-Reductase inhibitors (dutasteride and finasteride) are considered second-line therapy for BPH-related LUTS and are effective only in patients with an enlarged prostate. 5α-Reductase inhibitors function by preventing the conversion of testosterone to dihydroxytestosterone, inhibiting prostate growth. These agents must be taken for up to 6 months before symptomatic improvement may be seen. In patients with LUTS who have an enlarged prostate, combining a 5α-reductase inhibitor with an α-blocker appears to be more effective than either agent alone. Side effects of 5α-reductase inhibitors include decreased libido, erectile dysfunction, breast tenderness, and gynecomastia. Although several trials have shown reduced incidence of low-grade prostate cancer with 5α-reductase inhibitors, there appears to be a slight increase in high-grade prostate cancer."
]
},
{
"type":"p",
"hlId":"b70939",
"children":[
"Antimuscarinic agents, such as trospium, oxybutynin, and tolterodine, can be used to treat bladder storage symptoms by relaxing bladder detrusor muscles. These are generally not used as monotherapy but instead in combination with other agents."
]
},
{
"type":"p",
"hlId":"0c9dcb",
"children":[
"Saw palmetto is frequently used to treat LUTS secondary to BPH but lacks data supporting its efficacy."
]
},
{
"type":"p",
"hlId":"9332c7",
"children":[
"Surgical treatment for LUTS secondary to BPH, most commonly transurethral resection of the prostate, is usually reserved for individuals who do not respond to pharmacotherapy or develop BPH complications, such as urinary retention or persistent gross hematuria."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"d548ee",
"children":[
"All patients with lower urinary tract symptoms should undergo a digital rectal examination to assess prostate size and contour, rectal sphincter tone, and perineal sensation."
]
},
{
"type":"keypoint",
"hlId":"ab6815",
"children":[
"α-Blockers are considered first-line pharmacotherapy for benign prostatic hyperplasia; combining a 5α-reductase inhibitor with an α-blocker appears to be more effective than either agent alone."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s6_5",
"title":{
"__html":"Acute Testicular and Scrotal Pain"
},
"titleNode":{
"type":"section-title",
"hlId":"e7d4a7",
"children":[
"Acute Testicular and Scrotal Pain"
]
},
"children":[
{
"type":"p",
"hlId":"a3279e",
"children":[
"Evaluation of acute testicular and scrotal pain should begin with a concise history focusing on pain characteristics, associated symptoms, trauma history, previous urologic disorders, and sexual history, followed by a focused genitourinary examination."
]
},
{
"type":"p",
"hlId":"d3bd87",
"children":[
"Testicular torsion is the most important diagnosis to rule out initially. Although it is most common in younger men, it can occur at any age. Testicular torsion involves twisting of the spermatic cord structures, leading to ischemia and eventual infarction of the testis. It is most commonly characterized by acute onset of severe pain in one testis that rapidly progresses in severity over a period of hours and may be accompanied by nausea and vomiting. Examination findings include an exquisitely tender and swollen testis that is elevated with erythema of the overlying scrotal skin. The cremasteric reflex, testicular elevation in response to stroking the inner thigh, is typically absent. If testicular torsion is suspected, patients should not undergo imaging studies and instead be directly referred for immediate exploratory surgery because surgical delay reduces the probability of testicular viability."
]
},
{
"type":"p",
"hlId":"f82815",
"children":[
"Epididymitis is usually secondary to infection; when infection spreads to the adjacent testis, it is termed epididymo-orchitis. Both conditions typically cause unilateral scrotal pain of gradual onset that worsens over a period of days. In younger patients (age ≤35 years), ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Chlamydia trachomatis"
]
},
" and ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria gonorrhoeae"
]
},
" are the most commonly implicated pathogens. In men older than 35 years and those at low risk for sexually transmitted infections, colonic bacteria, such as ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Escherichia coli,"
]
},
" are the most common pathogens. Examination reveals tenderness and swelling of involved structures. Pain may be relieved with scrotal elevation. Urinalysis and culture should be obtained in all patients, as well as testing for sexually transmitted infections when suspicion is high. Imaging is usually not necessary. Treatment consists of empiric antimicrobial therapy directed toward the most likely pathogen ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t42",
"wrapId":"6",
"children":[
"Table 42"
]
}
]
},
")"
]
},
". Conservative measures include scrotal elevation, NSAIDs, and rest."
]
},
{
"type":"inline-wrap",
"wrapId":"6",
"contentIds":[
"mk19_b_gm_t42"
]
},
{
"type":"p",
"hlId":"c7349a",
"children":[
"Other causes of acute testicular and scrotal pain are described in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t43",
"wrapId":"7",
"children":[
"Table 43"
]
}
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"7",
"contentIds":[
"mk19_b_gm_t43"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"01f882",
"children":[
"Testicular torsion presents as acute, unilateral, severe scrotal pain and swelling with an elevated testis on examination and absent cremasteric reflex; it is a surgical emergency."
]
},
{
"type":"keypoint",
"hlId":"e69d0d",
"children":[
"Epididymitis and epididymo-orchitis are treated with empiric antimicrobial therapy directed toward the most likely pathogen."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s6_6",
"title":{
"__html":"Hydrocele, Varicocele, and Epididymal Cyst"
},
"titleNode":{
"type":"section-title",
"hlId":"a45283",
"children":[
"Hydrocele, Varicocele, and Epididymal Cyst"
]
},
"children":[
{
"type":"p",
"hlId":"da4233",
"children":[
"Hydroceles form when fluid accumulates within the space between the visceral and parietal layers of the tunica vaginalis ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_b_gm_f03",
"wrapId":"8",
"children":[
"Figure 3"
]
}
]
},
")"
]
},
". The suspected etiology is an imbalance between fluid secretion and reabsorption by the tunica vaginalis. Symptoms include scrotal swelling and pain. On scrotal transillumination, light shines through the scrotum. Asymptomatic hydroceles require no intervention, whereas patients with bothersome symptoms can be referred for surgical excision of the hydrocele sac. Simple fluid aspiration is usually ineffective because fluid often reaccumulates."
]
},
{
"type":"inline-wrap",
"wrapId":"8",
"contentIds":[
"mk19_b_gm_f03"
]
},
{
"type":"p",
"hlId":"baab48",
"children":[
"Varicoceles occur in 15% to 20% of adult men and are caused by dilation of the pampiniform plexus of the spermatic veins. Symptoms include scrotal swelling and dull and/or aching pain. On examination, the swelling has a “bag of worms” consistency that becomes smaller with scrotal elevation. Accompanying testicular atrophy may be observed. Although most commonly left-sided, varicoceles can also be right-sided or bilateral. Varicoceles are also associated with male infertility. In patients who are minimally symptomatic with no testicular atrophy, conservative measures (such as NSAIDs and scrotal support) are recommended. For patients with bothersome symptoms or those with testicular atrophy on examination who desire to have children, either surgical ligation (preferred) or percutaneous venous embolization is recommended."
]
},
{
"type":"p",
"hlId":"69c8dc",
"children":[
"Epididymal cysts are soft rounded structures in the head of the epididymis; when larger than 2 cm, they are termed spermatoceles. They are usually asymptomatic and require no intervention, but larger painful spermatoceles can be surgically excised."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s6_7",
"title":{
"__html":"Acute and Chronic Prostatitis and Pelvic Pain"
},
"titleNode":{
"type":"section-title",
"hlId":"931ae2",
"children":[
"Acute and Chronic Prostatitis and Pelvic Pain"
]
},
"children":[
{
"type":"p",
"hlId":"8a1026",
"children":[
"Prostatitis has an estimated prevalence of 9.7%. According to the National Institutes of Health consensus classification, there are four categories of prostatitis ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t44",
"wrapId":"9",
"children":[
"Table 44"
]
}
]
},
")"
]
},
". Assessment of patients with suspected prostatitis begins with a thorough history, including assessment of urinary and systemic symptoms and urologic and sexual history. Vital sign assessment and abdominal, genital, and digital rectal examinations should be performed. Urinalysis and urine culture should be obtained in all patients."
]
},
{
"type":"inline-wrap",
"wrapId":"9",
"contentIds":[
"mk19_b_gm_t44"
]
},
{
"type":"p",
"hlId":"9c5734",
"children":[
"Patients with acute bacterial prostatitis typically present with acute onset of local symptoms (dysuria, urinary frequency and urgency, suprapubic and/or rectal pain) and systemic symptoms (fevers, chills, nausea/vomiting, malaise). Digital rectal examination reveals an enlarged, tender, and often boggy prostate. Prostate massage may lead to bacteremia and should be avoided. Empiric antimicrobial therapy should be initiated at time of diagnosis and modified as appropriate on the basis of urine culture results. Most patients can be managed with oral agents as outpatients, but severely ill patients and those with suspected sepsis should be hospitalized and initially treated with parenteral antibiotics ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t45",
"wrapId":"10",
"children":[
"Table 45"
]
}
]
},
")"
]
},
". Antimicrobial agents are typically continued for 2 to 4 weeks; some experts recommend up to 6 weeks."
]
},
{
"type":"inline-wrap",
"wrapId":"10",
"contentIds":[
"mk19_b_gm_t45"
]
},
{
"type":"p",
"hlId":"48f7db",
"children":[
"Chronic bacterial prostatitis involves persistent prostate infection lasting longer than 3 months. It commonly manifests as recurrent lower urinary tract infections with the same organism. On digital rectal examination, the prostate may be normal, tender, and/or boggy. In patients with an initially negative urine culture, a repeat urine culture obtained after prostate massage can increase the likelihood of identifying the causative organism. Antimicrobial therapy is similar to that used for acute bacterial prostatitis and should be guided by urine culture results and continued for 4 to 6 weeks."
]
},
{
"type":"p",
"hlId":"6b5824",
"children":[
"More than 90% of patients with prostatitis have chronic prostatitis/pelvic pain syndrome without evidence of infection. Symptoms vary widely and include chronic urinary symptoms, pelvic pain, and pain with ejaculation. Although there is no clearly established first-line treatment, α-blockers, NSAIDs, and extended courses of antimicrobials with good prostatic tissue penetration are frequently used. Pharmacotherapy should not be repeated if no improvement is noted after an initial course of appropriate duration. Approximately 30% of patients will improve with or without therapy."
]
},
{
"type":"p",
"hlId":"b6fde1",
"children":[
"Asymptomatic inflammatory prostatitis is usually diagnosed when urologic evaluation is performed for other indications, such as prostate biopsy for an elevated PSA level. The significance of this form of prostatitis is unclear and, when present without symptoms, does not require specific therapy."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"7e6def",
"children":[
"Oral ciprofloxacin, levofloxacin, and trimethoprim-sulfamethoxazole are options for treating acute bacterial prostatitis; severely ill patients and those with suspected sepsis should be hospitalized and initially treated with parenteral antibiotics."
]
},
{
"type":"keypoint",
"hlId":"19189a",
"children":[
"Although there is no clearly established first-line treatment for chronic pelvic pain syndrome, α-blockers, NSAIDs, and extended courses of antimicrobials with good prostatic tissue penetration are frequently used."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s6_8",
"title":{
"__html":"Hernias"
},
"titleNode":{
"type":"section-title",
"hlId":"875f1e",
"children":[
"Hernias"
]
},
"children":[
{
"type":"p",
"hlId":"e454bd",
"children":[
"A hernia is a protrusion of tissue through a defect in the surrounding fascia. Inguinal hernias, which account for nearly 75% of hernias in men, may be asymptomatic but may present as groin pain and a scrotal or inguinal bulge. Indirect inguinal hernias, the most common type, originate at the internal inguinal ring, pass through the inguinal canal and external inguinal ring, and may descend into the scrotum. Direct inguinal hernias originate near the external inguinal ring and usually do not descend into the scrotum. Examination may reveal a visible or palpable bulge in the groin or scrotum that is accentuated by the Valsalva maneuver. Inguinal hernia diagnosis is usually clinical, and imaging studies are rarely needed."
]
},
{
"type":"p",
"hlId":"6d2d3e",
"children":[
"Small, asymptomatic or minimally symptomatic inguinal hernias may be observed or undergo surgical repair; patients in whom repair is deferred should be advised to seek emergent care if they develop increasing pain or symptoms of bowel obstruction. Large or bothersome inguinal hernias are usually repaired surgically. Laparoscopic and open approaches have similar outcomes, but recovery time is shorter for the former. Surgical complications of both methods include hematomas, seromas, and wound infection. Incarcerated or nonreducible hernias can be reduced by applying pressure to the area with the patient in the Trendelenburg position. If the hernia remains nonreducible, then surgical evaluation should occur. Strangulation of a nonreducible hernia is a surgical emergency because it represents vascular compromise of the entrapped hernia. Strangulation should be suspected when there is significant tenderness, overlying erythema, and accompanying nausea and vomiting."
]
},
{
"type":"p",
"hlId":"d58142",
"children":[
"Athletic pubalgia (sports hernia) is caused by tearing of groin muscle fibers and should be suspected in athletes who participate in high-intensity activities and are experiencing hernia-like symptoms but who have no palpable bulge on examination. Initial treatment consists of rest, physical therapy, and NSAIDs. Surgery is reserved for those in whom conservative measures fail."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"97f7ec",
"hvc":true,
"children":[
"Small, asymptomatic or minimally symptomatic inguinal hernias may be observed or undergo surgical repair."
]
},
{
"type":"keypoint",
"hlId":"ca6a67",
"children":[
"Strangulation of a nonreducible hernia is a surgical emergency and should be suspected when there is significant tenderness, overlying erythema, and accompanying nausea and vomiting."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s6_9",
"bibliography":true,
"title":{
"__html":"Bibliography"
},
"titleNode":{
"type":"section-title",
"hlId":"a7cc81",
"children":[
"Bibliography"
]
},
"children":[
{
"type":"references",
"children":[
{
"type":"reference",
"children":[
"Barry MJ, Fowler FJ Jr, O’Leary MP, et al; Measurement Committee of the American Urological Association. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 2017;197:S189-97. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28012747",
"target":"_blank"
},
"children":[
"PMID: 28012747"
]
},
" doi:10.1016/j.juro.2016.10.071"
]
},
{
"type":"reference",
"children":[
"Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200:633-41. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29746858",
"target":"_blank"
},
"children":[
"PMID: 29746858"
]
},
" doi:10.1016/j.juro.2018.05.004"
]
},
{
"type":"reference",
"children":[
"Gill BC, Shoskes DA. Bacterial prostatitis. Curr Opin Infect Dis. 2016;29:86-91. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/26555038",
"target":"_blank"
},
"children":[
"PMID: 26555038"
]
},
" doi:10.1097/QCO.0000000000000222"
]
},
{
"type":"reference",
"children":[
"Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I-initial work-up and medical management. J Urol. 2021;206:806-817. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/34384237",
"target":"_blank"
},
"children":[
"PMID: 34384237"
]
},
" doi:10.1097/JU.0000000000002183"
]
},
{
"type":"reference",
"children":[
"Li X, Li J, Li X, et al. Effectiveness and safety of fluoxetine for premature ejaculation: Protocol for a systematic review. Medicine (Baltimore). 2019;98:e14481. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30762772",
"target":"_blank"
},
"children":[
"PMID: 30762772"
]
},
" doi:10.1097/MD.0000000000014481"
]
},
{
"type":"reference",
"children":[
"Liu H, Zhang M, Huang M, et al. Comparative efficacy and safety of drug treatment for premature ejaculation: a systemic review and Bayesian network meta-analysis. Andrologia. 2020:e13806. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/32892379",
"target":"_blank"
},
"children":[
"PMID: 32892379"
]
},
" doi:10.1111/and.13806"
]
},
{
"type":"reference",
"children":[
"Lorenzo L, Rogel R, Sanchez-Gonzalez JV, et al. Evaluation of adult acute scrotum in the emergency room: clinical characteristics, diagnosis, management, and costs. Urology. 2016;94:36-41. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/27210570",
"target":"_blank"
},
"children":[
"PMID: 27210570"
]
},
" doi:10.1016/j.urology.2016.05.018"
]
},
{
"type":"reference",
"children":[
"Martin C, Nolen H, Podolnick J, et al. Current and emerging therapies in premature ejaculation: where we are coming from, where we are going. Int J Urol. 2017;24:40-50. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/27704632",
"target":"_blank"
},
"children":[
"PMID: 27704632"
]
},
" doi:10.1111/iju.13202"
]
},
{
"type":"reference",
"children":[
"Montgomery J, Dimick JB, Telem DA. Management of groin hernias in adults—2018. JAMA. 2018;320:1029-30. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30128503",
"target":"_blank"
},
"children":[
"PMID: 30128503"
]
},
" doi:10.1001/jama.2018.10680emprici"
]
},
{
"type":"reference",
"children":[
"Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200:423-32. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29601923",
"target":"_blank"
},
"children":[
"PMID: 29601923"
]
},
" doi:10.1016/j.juro.2018.03.115"
]
},
{
"type":"reference",
"children":[
"Pirola GM, Verdacchi T, Rosadi S, et al. Chronic prostatitis: current treatment options. Res Rep Urol. 2019;11:165-74. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31240202",
"target":"_blank"
},
"children":[
"PMID: 31240202"
]
},
" doi:10.2147/RRU.S194679"
]
},
{
"type":"reference",
"children":[
"Qaseem A, Horwitch CA, Vijan S, et al; Clinical Guidelines Committee of the American College of Physicians. Testosterone treatment in adult men with age-related low testosterone: a clinical guideline from the American College of Physicians. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"https://www.acpjournals.org/doi/10.7326/M19-0882",
"target":"_blank"
},
"children":[
"Ann Intern Med"
]
},
". 2020;172:126-33. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31905405",
"target":"_blank"
},
"children":[
"PMID: 31905405"
]
}
]
},
{
"type":"reference",
"children":[
"Sharlip ID, Belker AM, Honig S, et al; American Urological Association. Vasectomy: AUA guideline. J Urol. 2012;188:2482-91. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/23098786",
"target":"_blank"
},
"children":[
"PMID: 23098786"
]
},
" doi:10.1016/j.juro.2012.09.080"
]
}
]
}
]
}
]
},
"tablesContent":{
"mk19_b_gm_t37":{
"id":"mk19_b_gm_t37",
"number":37,
"bookId":"gm2",
"title":{
"__html":"Drugs Commonly Associated With Erectile Dysfunction"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"dde29a",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 37. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t37"
}
]
},
"Drugs Commonly Associated With Erectile Dysfunction"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f26a57",
"class":"cell txt l",
"children":[
"Antidepressants (monoamine oxidase inhibitors, selective serotonin reuptake inhibitors, tricyclic antidepressants)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"521c0d",
"class":"cell txt l",
"children":[
"Benzodiazepines"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e839b6",
"class":"cell txt l",
"children":[
"Opioids, nicotine, alcohol, amphetamines, barbiturates, cocaine, marijuana"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9bb0b6",
"class":"cell txt l",
"children":[
"Anticonvulsants (phenytoin, phenobarbital)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"92f4b9",
"class":"cell txt l",
"children":[
"Antihypertensives and diuretics (thiazide diuretics, loop diuretics, clonidine, spironolactone; possibly α-blockers, β-blockers, calcium channel blockers, ACE inhibitors)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"19f04a",
"class":"cell txt l",
"children":[
"5α-Reductase inhibitors (dutasteride, finasteride)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"67243d",
"class":"cell txt l",
"children":[
"Antihistamines and H",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"-blockers (dimenhydrinate, diphenhydramine, hydroxyzine, meclizine, promethazine, cimetidine, nizatidine, ranitidine)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4824df",
"class":"cell txt l",
"children":[
"NSAIDs (naproxen, indomethacin)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7a4f98",
"class":"cell txt l",
"children":[
"Parkinson disease medications (levodopa, bromocriptine, biperiden, trihexyphenidyl, benztropine, procyclidine)"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_b_gm_t38":{
"id":"mk19_b_gm_t38",
"number":38,
"bookId":"gm2",
"title":{
"__html":"Third Princeton Consensus Conference Guidelines for Treatment of Erectile Dysfunction in Patients With Cardiovascular Disease or Cardiac Risk Factors"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"c67ed2",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 38. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t38"
}
]
},
"Third Princeton Consensus Conference Guidelines for Treatment of Erectile Dysfunction in Patients With Cardiovascular Disease or Cardiac Risk Factors"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f9bf0a",
"class":"col hd l",
"children":[
"Risk Level"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"169855",
"class":"col hd l",
"children":[
"Treatment Recommendation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"36b152",
"class":"col hd l",
"children":[
"Low Risk"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e1c9cf",
"class":"cell txt l",
"children":[
"Patients who are able to do moderate-intensity exercise without symptoms"
]
},
" ",
{
"type":"p",
"hlId":"5ccbc7",
"class":"cell txt l",
"children":[
"Successfully revascularized patients (e.g., coronary artery bypass grafting, coronary stenting, or angioplasty)"
]
},
" ",
{
"type":"p",
"hlId":"e89726",
"class":"cell txt l",
"children":[
"Asymptomatic controlled hypertension"
]
},
" ",
{
"type":"p",
"hlId":"c3705e",
"class":"cell txt l",
"children":[
"Mild valvular disease"
]
},
" ",
{
"type":"p",
"hlId":"1a60f8",
"class":"cell txt l",
"children":[
"Mild left ventricular dysfunction (NYHA functional class I or II) who can achieve 5 METs without ischemia as determined by recent exercise testing"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d5aed8",
"class":"cell txt l",
"children":[
"Can initiate or resume sexual activity or treat for ED with a PDE-5 inhibitor (if not using nitrates)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"c6bc08",
"class":"col hd l",
"children":[
"Intermediate/Indeterminate Risk"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5dfe4f",
"class":"cell txt l",
"children":[
"Mild to moderate stable angina"
]
},
" ",
{
"type":"p",
"hlId":"7e040b",
"class":"cell txt l",
"children":[
"Recent MI (2-8 wk ago) without intervention and awaiting exercise ECG"
]
},
" ",
{
"type":"p",
"hlId":"f3de03",
"class":"cell txt l",
"children":[
"Heart failure (NYHA functional class III)"
]
},
" ",
{
"type":"p",
"hlId":"595e6e",
"class":"cell txt l",
"children":[
"Noncardiac atherosclerotic disease (clinically evident PAD, history of stroke/TIA)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e74d06",
"class":"cell txt l",
"children":[
"Further cardiac evaluation and restratification before resumption of sexual activity or treatment for ED"
]
},
" ",
{
"type":"p",
"hlId":"61d422",
"class":"cell txt l",
"children":[
"If the patient can complete 4 minutes of the standard Bruce treadmill protocol without symptoms, arrhythmias, or a decrease in blood pressure, treatment for ED can be safely initiated"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"d0bf2d",
"class":"col hd l",
"children":[
"High Risk"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3c436f",
"class":"cell txt l",
"children":[
"Unstable or refractory angina"
]
},
" ",
{
"type":"p",
"hlId":"d7d548",
"class":"cell txt l",
"children":[
"Uncontrolled hypertension"
]
},
" ",
{
"type":"p",
"hlId":"a97952",
"class":"cell txt l",
"children":[
"Moderate to severe heart failure (NYHA functional class IV)"
]
},
" ",
{
"type":"p",
"hlId":"1f3263",
"class":"cell txt l",
"children":[
"Recent MI (<2 wk ago) without intervention"
]
},
" ",
{
"type":"p",
"hlId":"1b15a0",
"class":"cell txt l",
"children":[
"High-risk arrhythmia (exercise-induced ventricular tachycardia, ICD with frequent shocks, poorly controlled atrial fibrillation)"
]
},
" ",
{
"type":"p",
"hlId":"8e8a7d",
"class":"cell txt l",
"children":[
"Obstructive hypertrophic cardiomyopathy with severe symptoms"
]
},
" ",
{
"type":"p",
"hlId":"e9c9dc",
"class":"cell txt l",
"children":[
"Moderate to severe valvular disease (particularly aortic stenosis)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ce3eb5",
"class":"cell txt l",
"children":[
"Defer sexual activity or ED treatment until cardiac condition is stabilized and reassessed"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"ED = erectile dysfunction; ICD = implantable cardioverter-defibrillator; METs = metabolic equivalents; MI = myocardial infarction; NYHA = New York Heart Association; PAD = peripheral artery disease; PDE = phosphodiesterase; TIA = transient ischemic attack."
],
[
"Recommendations from Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87:766-78. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/22862865",
"target":"_blank"
},
"children":[
"PMID: 22862865"
]
},
" doi:10.1016/j.mayocp.2012.06.015"
]
]
},
"mk19_b_gm_t39":{
"id":"mk19_b_gm_t39",
"number":39,
"bookId":"gm2",
"title":{
"__html":"Pregnancy Rates With Use of Male Contraception"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"9bf798",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 39. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t39"
}
]
},
"Pregnancy Rates With Use of Male Contraception"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"col hd l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"bffca0",
"class":"col hd c",
"children":[
"Women Experiencing Unintended Pregnancy Within First Year of Use (%)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4c3880",
"class":"col hd l",
"children":[
"Method"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1ad2d1",
"class":"col hd c",
"children":[
"Perfect Use",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
" (Efficacy)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"561d0c",
"class":"col hd c",
"children":[
"Typical Use",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
" (Effectiveness)"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d58763",
"class":"cell txt l",
"children":[
"Male condoms"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9d2487",
"class":"cell txt c",
"children":[
"2%"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"99961f",
"class":"cell txt c",
"children":[
"13%"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fa8cd3",
"class":"cell txt l",
"children":[
"Withdrawal method"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cdf80b",
"class":"cell txt c",
"children":[
"4%"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a95b98",
"class":"cell txt c",
"children":[
"20%"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3d92d5",
"class":"cell txt l",
"children":[
"Vasectomy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7a0822",
"class":"cell txt c",
"children":[
"0.1%"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2ad75f",
"class":"cell txt c",
"children":[
"0.15%"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Use of the contraceptive method exactly as instructed during each and every episode of sexual intercourse."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"All users of a particular method, including those who use it perfectly, those who use it correctly but do not use the method every time, those who use the method every time but not always correctly, and those who always use the method but do so incorrectly."
],
[
"Adapted from Trussell J, Aiken ARA. Contraceptive efficacy. In: Hatcher RA, Nelson AL, Trussell J, Cwiak C, Cason P, Policar MS, Edelman A, Aiken ARA, Marrazzo J, Kowal D, eds. Contraceptive technology. 21st ed. New York, NY: Ayer Company Publishers, Inc., 2018."
]
]
},
"mk19_b_gm_t40":{
"id":"mk19_b_gm_t40",
"number":40,
"bookId":"gm2",
"title":{
"__html":"Symptoms and Signs Suggestive of Androgen Deficiency in Men"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"4f1c3c",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 40. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t40"
}
]
},
"Symptoms and Signs Suggestive of Androgen Deficiency in Men"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f1c5c1",
"class":"col hd l",
"children":[
"More Specific Symptoms and Signs"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4ccbfc",
"class":"cell txt l",
"children":[
"Incomplete or delayed sexual development, eunuchoidism"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"29b3e6",
"class":"cell txt l",
"children":[
"Reduced sexual desire (libido) and activity"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b2f188",
"class":"cell txt l",
"children":[
"Decreased spontaneous erections"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"36fa55",
"class":"cell txt l",
"children":[
"Breast discomfort, gynecomastia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c39256",
"class":"cell txt l",
"children":[
"Loss of body (axillary and pubic) hair, reduced shaving"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d554df",
"class":"cell txt l",
"children":[
"Very small (especially <5 mL) or shrinking testes"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"146e68",
"class":"cell txt l",
"children":[
"Inability to father children, low or zero sperm count"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8c4935",
"class":"cell txt l",
"children":[
"Height loss, low-trauma fracture, low bone mineral density"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6115a1",
"class":"cell txt l",
"children":[
"Hot flushes, sweats"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2b1c69",
"class":"col hd l",
"children":[
"Other, Less Specific Symptoms and Signs"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ded69e",
"class":"cell txt l",
"children":[
"Decreased energy, motivation, initiative, and self-confidence"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"77f13a",
"class":"cell txt l",
"children":[
"Feeling sad or blue, depressed mood, dysthymia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3e60c3",
"class":"cell txt l",
"children":[
"Poor concentration and memory"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ce04d3",
"class":"cell txt l",
"children":[
"Sleep disturbance, increased sleepiness"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"47ac7f",
"class":"cell txt l",
"children":[
"Mild anemia (normochromic, normocytic, in the female range)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"350008",
"class":"cell txt l",
"children":[
"Reduced muscle bulk and strength"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c8d97c",
"class":"cell txt l",
"children":[
"Increased body fat, BMI"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e00709",
"class":"cell txt l",
"children":[
"Diminished physical or work performance"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"Reproduced from Bhasin S, Cunningham GR, Hayes FJ, et al; Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:2536-59. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/20525905",
"target":"_blank"
},
"children":[
"PMID: 20525905"
]
},
" doi:10.1210/jc.2009-2354. Copyright 2010, The Endocrine Society. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"https://creativecommons.org/licenses/by-nc-nd/4.0/",
"target":"_blank"
},
"children":[
"https://creativecommons.org/licenses/by-nc-nd/4.0/"
]
},
")."
]
]
},
"mk19_b_gm_t41":{
"id":"mk19_b_gm_t41",
"number":41,
"bookId":"gm2",
"title":{
"__html":"Causes of Lower Urinary Tract Symptoms in Men"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"1fe237",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 41. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t41"
}
]
},
"Causes of Lower Urinary Tract Symptoms in Men"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b39c66",
"class":"cell txt l",
"children":[
"Benign prostatic hyperplasia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bcd2b3",
"class":"cell txt l",
"children":[
"Medications (diuretics, anticholinergics, sympathomimetics, antihistamines, opioids)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a42e88",
"class":"cell txt l",
"children":[
"Bladder irritants (caffeine, alcohol, spicy and acid-rich foods, carbonated beverages)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a495cc",
"class":"cell txt l",
"children":[
"Overactive bladder/detrusor dysfunction"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f32e29",
"class":"cell txt l",
"children":[
"Urethral strictures"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ec489b",
"class":"cell txt l",
"children":[
"Bladder stones"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b06664",
"class":"cell txt l",
"children":[
"Urinary tract infections"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"99932d",
"class":"cell txt l",
"children":[
"Urethritis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b805b5",
"class":"cell txt l",
"children":[
"Prostatitis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-10 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f9615f",
"class":"cell txt l",
"children":[
"Prostate cancer"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-11 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e46241",
"class":"cell txt l",
"children":[
"Bladder cancer"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-12 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5d0c99",
"class":"cell txt l",
"children":[
"Polydipsia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-13 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"05159a",
"class":"cell txt l",
"children":[
"Diabetes mellitus"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-14 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ca8640",
"class":"cell txt l",
"children":[
"Hypercalcemia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-15 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e6b25a",
"class":"cell txt l",
"children":[
"Spinal cord injury"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-16 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fb6891",
"class":"cell txt l",
"children":[
"Parkinson disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-17 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c0a038",
"class":"cell txt l",
"children":[
"Neurogenic bladder"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-18 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0bf538",
"class":"cell txt l",
"children":[
"Obstructive sleep apnea"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_b_gm_t42":{
"id":"mk19_b_gm_t42",
"number":42,
"bookId":"gm2",
"title":{
"__html":"Empiric Antimicrobial Therapy for Epididymitis and Epididymo-orchitis"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"f32ced",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 42. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t42"
}
]
},
"Empiric Antimicrobial Therapy for Epididymitis and Epididymo-orchitis"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a59220",
"class":"col hd l",
"children":[
"Patient Group"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8b7674",
"class":"col hd l",
"children":[
"Therapy"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6c345e",
"class":"cell txt l",
"children":[
"Age ≤35 y"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"375fbc",
"class":"cell txt l",
"children":[
"Intramuscular ceftriaxone and oral doxycycline"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d9ef81",
"class":"cell txt l",
"children":[
"Age >35 y"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c604a7",
"class":"cell txt l",
"children":[
"Oral levofloxacin"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"108526",
"class":"cell txt l",
"children":[
"Age >35 y and at risk for chlamydia or gonococcal infection"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"375fbc",
"class":"cell txt l",
"children":[
"Intramuscular ceftriaxone and oral doxycycline"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d8fad3",
"class":"cell txt l",
"children":[
"All men who practice insertive anal intercourse"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9e18d7",
"class":"cell txt l",
"children":[
"Intramuscular ceftriaxone and oral levofloxacin"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_b_gm_t43":{
"id":"mk19_b_gm_t43",
"number":43,
"bookId":"gm2",
"title":{
"__html":"Other Causes of Acute Testicular and Scrotal Pain"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"34e856",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 43. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t43"
}
]
},
"Other Causes of Acute Testicular and Scrotal Pain"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"50fc9b",
"class":"col hd l",
"children":[
"Cause"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c7bc3f",
"class":"col hd l",
"children":[
"Presentation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"523223",
"class":"col hd l",
"children":[
"Diagnosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4c4ac0",
"class":"col hd l",
"children":[
"Treatment"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"092bf7",
"class":"col hd l",
"children":[
"Additional Information"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"30f8c2",
"class":"cell txt l",
"children":[
"Torsion of appendix testis and appendix epididymis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3d45e3",
"class":"cell txt l",
"children":[
"Similar presentation to testicular torsion"
]
},
" ",
{
"type":"p",
"hlId":"b8c718",
"class":"cell txt l",
"children":[
"“Blue dot sign” on examination (ischemic structures seen beneath scrotal skin)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"526504",
"class":"cell txt l",
"children":[
"Examination (although often diagnosed during surgical exploration)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f3dc44",
"class":"cell txt l",
"children":[
"Immediate urology referral for evaluation"
]
},
" ",
{
"type":"p",
"hlId":"738a59",
"class":"cell txt l",
"children":[
"Surgery often required to rule out testicular torsion"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"15de45",
"class":"cell txt l",
"children":[
"Self-limited condition; testicular torsion must be ruled out"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"117ee1",
"class":"cell txt l",
"children":[
"Testicular malignancy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"97ddca",
"class":"cell txt l",
"children":[
"Typically presents as a painless testicular mass; in 15% of cases, presents with either acute onset or indolent dull, achy pain"
]
},
" ",
{
"type":"p",
"hlId":"1883c8",
"class":"cell txt l",
"children":[
"Firm, fixed, palpable mass on surface of testis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c576c6",
"class":"cell txt l",
"children":[
"Examination"
]
},
" ",
{
"type":"p",
"hlId":"a79038",
"class":"cell txt l",
"children":[
"Ultrasonography"
]
},
" ",
{
"type":"p",
"hlId":"4d5712",
"class":"cell txt l",
"children":[
"Tumor markers (α-fetoprotein, β-human chorionic gonadotropin, lactate dehydrogenase)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4cc2ab",
"class":"cell txt l",
"children":[
"Surgery"
]
},
" ",
{
"type":"p",
"hlId":"d120b1",
"class":"cell txt l",
"children":[
"Chemotherapy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"071e97",
"class":"cell txt l",
"children":[
"Most common malignancy in men aged <40 y"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2e59a7",
"class":"cell txt l",
"children":[
"Viral orchitis (e.g., mumps, rubella)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e60ec3",
"class":"cell txt l",
"children":[
"Bilateral testicular pain and swelling"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c576c6",
"class":"cell txt l",
"children":[
"Examination"
]
},
" ",
{
"type":"p",
"hlId":"4323a9",
"class":"cell txt l",
"children":[
"Serologies"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"18e685",
"class":"cell txt l",
"children":[
"Analgesia with NSAIDs"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"62ebc3",
"class":"cell txt l",
"children":[
"Occurs in 20%-30% of men with mumps"
]
},
" ",
{
"type":"p",
"hlId":"d90c9e",
"class":"cell txt l",
"children":[
"Orchitis without epididymitis should raise concern for mumps"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3ed830",
"class":"cell txt l",
"children":[
"Nephrolithiasis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cb8fc9",
"class":"cell txt l",
"children":[
"Pain typically starts in flank and radiates into anterior lower abdomen and groin/scrotum as stone migrates into lower ureter"
]
},
" ",
{
"type":"p",
"hlId":"091f16",
"class":"cell txt l",
"children":[
"Examination of scrotum and testes are normal"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"747c2a",
"class":"cell txt l",
"children":[
"Urinalysis"
]
},
" ",
{
"type":"p",
"hlId":"af5e52",
"class":"cell txt l",
"children":[
"Imaging (ultrasonography, or noncontrast helical CT)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"af7a39",
"class":"cell txt l",
"children":[
"Encourage oral intake of fluids"
]
},
" ",
{
"type":"p",
"hlId":"18e685",
"class":"cell txt l",
"children":[
"Analgesia with NSAIDs"
]
},
" ",
{
"type":"p",
"hlId":"8ff20e",
"class":"cell txt l",
"children":[
"Tamsulosin"
]
},
" ",
{
"type":"p",
"hlId":"b9f475",
"class":"cell txt l",
"children":[
"Larger stones may require urologic extraction"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4ff48f",
"class":"cell txt l",
"children":[
"Presence of fever or evidence of systemic illness should raise concern for infected stone"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_b_gm_t44":{
"id":"mk19_b_gm_t44",
"number":44,
"bookId":"gm2",
"title":{
"__html":"National Institute of Health Consensus Definition and Classification of Prostatitis"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"704433",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 44. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t44"
}
]
},
"National Institute of Health Consensus Definition and Classification of Prostatitis"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3adbdb",
"class":"col hd l",
"children":[
"Category"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b5a7ad",
"class":"col hd l",
"children":[
"Description"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dd7536",
"class":"cell txt l",
"children":[
"I"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f5efbe",
"class":"cell txt l",
"children":[
"Acute bacterial prostatitis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"66cc12",
"class":"cell txt l",
"children":[
"II"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dbdb46",
"class":"cell txt l",
"children":[
"Chronic bacterial prostatitis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"51ac45",
"class":"cell txt l",
"children":[
"III"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"35a5be",
"class":"cell txt l",
"children":[
"Chronic prostatitis/chronic pelvic pain syndrome (A, inflammatory; B, noninflammatory)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cf482c",
"class":"cell txt l",
"children":[
"IV"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"197b52",
"class":"cell txt l",
"children":[
"Asymptomatic inflammatory prostatitis"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"Data from Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis [Letter]. JAMA. 1999;282:236-7. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/10422990",
"target":"_blank"
},
"children":[
"PMID: 10422990"
]
},
" doi:10.1001/jama.282.3.236"
]
]
},
"mk19_b_gm_t45":{
"id":"mk19_b_gm_t45",
"number":45,
"bookId":"gm2",
"title":{
"__html":"Empiric Antimicrobial Therapy for Acute Bacterial Prostatitis"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"be7935",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 45. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t45"
}
]
},
"Empiric Antimicrobial Therapy for Acute Bacterial Prostatitis"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f67792",
"class":"col hd l",
"children":[
"Oral Agents"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4385e4",
"class":"cell txt l",
"children":[
"Trimethoprim-sulfamethoxazole"
]
},
" ",
{
"type":"p",
"hlId":"950d42",
"class":"cell txt l",
"children":[
"Ciprofloxacin"
]
},
" ",
{
"type":"p",
"hlId":"0ac590",
"class":"cell txt l",
"children":[
"Levofloxacin"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"03d5ca",
"class":"col hd l",
"children":[
"Intravenous Agents",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"10db95",
"class":"cell txt l",
"children":[
"Ciprofloxacin ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"or"
]
},
" levofloxacin (alone or combined with gentamycin or tobramycin)"
]
},
" ",
{
"type":"p",
"hlId":"b47e8d",
"class":"cell txt l",
"children":[
"Cefotaxime ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"or"
]
},
" ceftazidime (alone or combined with gentamycin or tobramycin)"
]
},
" ",
{
"type":"p",
"hlId":"6f3a42",
"class":"cell txt l",
"children":[
"Piperacillin/tazobactam (alone or combined with gentamycin or tobramycin)"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"For patients unable to tolerate oral medication or who require hospitalization owing to severity of illness."
]
]
}
}
}